 |  |  |  |  |  |  |  |
| | | | | | | |
|
|
Overcoming Barriers to Immune Therapy in MelanomaSpeakersLinda Bradley, Ph.D. Sidney Kimmel Cancer Center San Diego, California, USA
Steffan Ho, M.D., Ph.D. Biogen Idec Inc. Molecular Discovery San Diego, California, USA
Kasper Hoebe, Ph.D. The Scripps Research Institute La Jolla, California, USA
Edith Jansen, Ph.D. The La Jolla Institute for Allergy and Immunology La Jolla, California, USA
Michael Karin, Ph.D. University of California, San Diego Cancer Biology Program La Jolla, California, USA
Thomas Kips, M.D., Ph.D. University of California, San Diego Division of Hematology/Oncology La Jolla, California, USA
Mitchell Kronenberg, Ph.D. The La Jolla Institute for Allergy and Immunology Division of Development Immunology La Jolla, California, USA
Davorka Messmer, Ph.D. University of California, San Diego Translation Oncology Program La Jolla, California, USA
Ann Moriarty, Ph.D. Johnson & Johnson Pharmaceutical Research & Development, LLC San Diego, California, USA
Antoni Ribas, M.D., Ph.D. University of California, Los Angeles Department of Medicine Division of Hematology and Oncology Los Angeles, California, USA
Heather M. Wilcox, Ph.D. MediVas, LLD San Diego, California, USA
Maurizio Zanetti, M.D. University of California, San Diego Translation Oncology Program San Diego, California, USA |
||||||||||
BioSymposia, Inc. is accredited by the Accreditation Council for Continuing Medical Education, the American Nurses Association's American Nurses Credentialing Center, and the Accreditation Council for Pharmacy Education. We also work with other key accreditors. This site contains medical information and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy. © 2008 BioSymposia, Inc., All rights reserved. |
|||||||||||
